Benzyl acrylate (stabilised with MEHQ), 99.00%, 500g

2-(Benzofuran-2-yl)ethanol, 98%, 250mg

N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acrylamide, 95.0%, 100mg

3',5'-dimethyl-3-(4-thiomethylphenyl)propiophenone, 97.0%, 1g

1-methyl-1H-indazole-3-carbonitrile, 95.0%, 1g

Ethyl 2-hydroxyimidazo[1,2-a]pyridine-3-carboxylate, 95.0%, 250mg

3H-Imidazo[4,5-c]pyridine-3,5(4H)-dicarboxylic acid, 2-(2-ethoxy-2-oxoethyl)-6,7-dihydro-, 3,5-bis(1,1-dimethylethyl) ester, 97%, 1g

(R)-1-Boc-3-Ethylpiperazine, 95.0%, 25g

1-(3-Nitro-2-pyridinyl)-3-azetanecarboxylic acid, 97.0%, 5g

Phase separating paper MN 616 WA, 100 Piece(s)

Spiro[piperidine-4,4'-pyrido[2,3-d][1,3]oxazin]-2'(1'H)-one hydrochloride, 95.0%, 5g

1-(4-Morpholinophenyl)ethanone, 95.0%, 100g

2-{[(2E)-3-phenylprop-2-en-1-yl]thio}nicotinic acid, 95.0%, 1g